 |
NYON, Switzerland, Oct. 12, 2020 /PRNewswire/ -- MedAlliance has announced enrolment of the first two patients in the PRISTINE registry with SELUTION SLR™ 018 DEB for the treatment of patients with Below The Knee disease (Chronic Limb Threatening Ischemia). This is the first DEB accepted by the FDA for its "Breakthrough Program". SELUTION...
The television personality and style favourite has curated her own jewellery edit and will front a new educational series tak...
An Australian food business could begin with this domain name, one that needs little explanation. The potential is right th...
Medow Health AI ip in another $3.5M into AI medtech capital raise Medow Health AI, the Australian health-tech company buildin...
Today, GoPro, Inc. (NASDAQ: GPRO) announced that its MISSION 1 Series of compact cinema cameras ha...
The Australian-born fitness brand is bringing its global competition home, with athletes from across...
Australians know exercise can improve their mental wellbeing, but new research from Australia’s se...
Every Australian family with school-aged children knows the pattern. Look at an airfare, hotel ro...
Australians know exercise can improve their mental wellbeing, but new research from Australia’s se...
Australian wellness destinations brought together movement, relaxation, sound and mindful experience...
AUSTRALIA’S BIGGEST OUTBACK MUSIC EVENT UNVEILS A MONSTER 2027 LINEUP The 2027 Broken Hill Mundi ...